Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aortic Regurgitation
88%
Randomized Trial
71%
Heparin
66%
Thrombolysis
66%
Ultrasound-assisted Thrombolysis
66%
Intermediate-risk Pulmonary Embolism
44%
Atrial Fibrillation
42%
All-cause Mortality
41%
Cardiovascular Disease
33%
Echo-guided
33%
Intracardiac Hemodynamics
33%
Diabetes
33%
Ventricular Remodeling
33%
Glycated Hemoglobin
33%
Copenhagen City Heart Study
33%
Hypertrophy Signaling
33%
Small Animal
33%
Early Onset
33%
Carvedilol
33%
Acute Aortic Regurgitation
33%
Late-onset
33%
Sildenafil
33%
Signaling Pathway
33%
Hemodynamic Assessment
33%
Prognostic Importance
33%
Ischemic Heart Disease
33%
Catheter Ablation
33%
Oral Anticoagulation
33%
Anticoagulant Therapy
33%
Acute Coronary Syndrome
33%
Coronary Computed Tomography Angiography
33%
Triage
33%
Invasive Coronary Angiography
33%
Trial Design
33%
Left Atrial Appendage Closure
33%
Diabetes Mellitus
33%
Design Analysis
33%
Cardiovascular Risk Factors
33%
Recombinant Tissue Plasminogen Activator (rt-PA)
33%
Pulmonary Embolism
33%
Statistical Analysis Plan
33%
Left Ventricular Dysfunction
27%
Left Ventricular Remodeling
19%
Glycated Hemoglobin A1c
16%
Blood Glucose
16%
Non-diabetic
16%
Health Problems
16%
Eccentric Hypertrophy
16%
Fractional Shortening
16%
Left Ventricular Function
16%
Medicine and Dentistry
Pulmonary Embolism
100%
Blood Clot Lysis
66%
Low Drug Dose
66%
Heparin
66%
Aortic Insufficiency
66%
Hemodynamic
55%
Heart Ventricle Remodeling
42%
Atrial Fibrillation
42%
Puncture
33%
Carvedilol
33%
Ablation
33%
Electrophysiology
33%
Pulmonary Vein Isolation
33%
Anticoagulant Therapy
33%
Anticoagulation
33%
Artificial Intelligence
33%
Lung
33%
Acute Coronary Syndrome
33%
Coronary Computed Tomography Angiography
33%
Triage
33%
Coronary Angiography
33%
Iodine
33%
Ischemic Heart Disease
33%
Sildenafil
33%
Oral
33%
Acute Pulmonary Embolism
26%
Echocardiography
21%
Dual Energy Computed Tomography
16%
Oxygen Saturation
16%
Recurrent Disease
15%
Bleeding
15%
Atrial Fibrillation Ablation
13%
Thoracotomy
11%
Arteriotomy
11%
Heart Disease
11%
Low Molecular Weight Heparin
10%
Heart Ventricle Function
9%
Arterial Embolism
9%
Bradycardia
9%
Pulmonary Vein
9%
Computed Tomography Angiography
8%
Deterioration
8%
All Cause Mortality
8%
Myocardial Infarction
8%
Obstruction
8%
Clinician
8%
Protein Kinase B
8%
Cardiac Fibrosis
8%
Treatment Effect
8%
Sham Procedure
8%
Pharmacology, Toxicology and Pharmaceutical Science
Aortic Regurgitation
66%
Bleeding
44%
Rat
40%
Atrial Fibrillation
33%
Heparin
33%
Lung Embolism
33%
Heart Ventricle Remodeling
33%
Sildenafil
33%
Artery Embolism
33%
Anticoagulant Agent
33%
Acute Coronary Syndrome
33%
All Cause Mortality
23%
Heart Infarction
23%
Randomized Controlled Trial
16%
Venous Thromboembolism
16%
Brain Ischemia
16%
Cerebrovascular Accident
16%
Cardiovascular Mortality
16%
Thrombus
16%
Heart Ventricle Hypertrophy
13%
Phosphotransferase
13%
Protein Kinase B
13%
Intravenous Route
11%
Heart Left Ventricle Failure
6%
Sprague Dawley Rat
6%
Heart Muscle Fibrosis
6%
Stress Activated Protein Kinase
6%
Fibrosis
6%
Calcineurin
6%
Heart Left Ventricle Hypertrophy
6%
Western Blot
6%
Calcium Calmodulin Dependent Protein Kinase II
6%
Major Adverse Cardiac Event
6%
Non ST Segment Elevation Myocardial Infarction
6%
Congestive Heart Failure
6%
Adverse Event
6%
Unstable Angina Pectoris
6%
Noninferiority Trial
6%
Deterioration
5%
Alteplase
5%
Fibrinolytic Agent
5%
